Skip to main content

Find Clinical Trials

Home
Conditions
AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs

Clinical trial condition

AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs

Explore clinical trials studying AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs trial results

Completed

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

NCT06119347

Conditions: AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
Locations: The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details